Long-term restricted cash and
investments 12,085 12,000
Other long-term assets 1,541 1,548
Total assets $258,767 $214,571
LIABILITIES, CONVERTIBLE PREFERRED
STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities:
Line of credit $2,597 $2,191
Accounts payable 2,872 5,443
Accrued liabilities 23,892 12,943
Deferred revenue 1,999 1,422
Preferred stock warrant liability - 8,521
Total current liabilities 31,360 30,520
Deferred rent and other non-current
liabilities - 534
Deferred revenue, non-current 12,752 13,495
Liability under government
settlement, non-current 14,881 -
Senior secured notes 74,862 74,283
Convertible preferred stock - 263,852
Common stock subject to repurchase 13,222 8,183
Stockholders' equity (deficit):
Common stock 2 -
Additional paid-in capital 368,136 1,335
Accumulated other comprehensive
income 1 12
Accumulated deficit (256,449) (177,643)
Total stockholders' equity (deficit) 111,690 (176,296)
Total liabilities, convertible
preferred stock and stockholders'
'/>"/>
| SOURCE Jazz Pharmaceuticals, Inc. Copyright©2007 PR Newswire. All rights reserved |